Shengqiang Zou

Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study

Jitao Wang, Zhiyun Hou, Jianxin Liu et al. · Journal of Hepatology · 2021 · 100 citations · Full text

Vaccination, Vaccine Safety, Hepatology +8

Hyaluronic acid-functionalized bismuth oxide nanoparticles for computed tomography imaging-guided radiotherapy of tumor

F. Du, Rong Jiang, Zhengzou Fang et al. · International Journal of Nanomedicine · 2017 · 99 citations · Full text

Fabrication of HA/PEI-functionalized carbon dots for tumor targeting, intracellular imaging and gene delivery

M. Zhang, Xin Zhao, Zhengzou Fang et al. · RSC Advances · 2017 · 94 citations · Full text

Nanoparticles, Engineering, Carbon Nanotechnology +23

miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2

Xu Zhang, Xueying Xu, Guohong Ge et al. · Oncology Reports · 2018 · 79 citations · Full text

Tumor Biology, Oncology, Hepatology +13

Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study

Jingwen Ai, Jitao Wang, Dengxiang Liu et al. · Clinical Gastroenterology and Hepatology · 2021 · 72 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8